GBM79 GBM Model

GBM79, a Patient-Derived Xenograft (PDX) model, is designed for brain cancer research. Investigate its characteristics to uncover new treatment avenues and deepen our understanding of the disease. PDX models like GBM79 are essential tools for preclinical drug discovery due to their ability to replicate patient-specific tumor environments. Researchers can use GBM79 to assess potential drug candidates, optimize treatment strategies, and accelerate the drug development process. GBM79 holds the promise of improving outcomes for brain cancer patients through targeted therapies.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM79
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide), Radiation (2Gy)
PDX Treatment: Yes
Patient Treatment History: Yes

GBM79 Survival

Survival of orthotopic intracranial implanted GBM79 in Nu/Nu mice (n=10)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content